Glycosmedia - an international diabetes news service from the UK
Archived News
September 12th 2008
  The Bendy Bus: a video viral
  After some ‘gruelling’ auditions, a long day’s filming and numerous edits, Diabetes UK is pleased to announce that we have successfully completed our first video highlighting the issues for people with Type 1 diabetes (Diabetes UK)
  DIAMAP - Invitation to diabetes researchers
  Invitation to diabetes researchers to participate in major new European project to map diabetes research (NDST, UK)
  ADVANCE helps clarify ACCORD mortality mystery but questions remain
  There has been great interest in ADVANCE following surprising results from the ACCORD (Action to Control Cardiovascular Risk in Diabetes) study which was terminated prematurely earlier this year due to a 22% increase in all cause mortality in patients whose blood glucose was aggressively controlled using regimens which included thiazolidinediones (PharmaTimes)
  Merck Serono's Glucophage(R) Powder for Oral Solution in Sachet Receives Positive Opinion for Approval in Europe
  Glucophage® Powder for Oral Solution in Sachet (metformin hydrochloride in 500mg, 850mg and 1000mg strengths) has received a positive opinion recommending approval for the first-line treatment of type 2 diabetes through a Decentralized Procedure (DCP) with France as the Reference Member State (BioSpace)
  Novartis presents new drug data
  New data show Galvus – an oral dipeptidyl peptidase 4 (DPP-4) inhibitor for type 2 diabetes – can lower blood sugar without the risk of producing hypoglycaemic attacks (Pharmacy Europe)
  Uncovering Glucose Abnormalities in People With Hepatitis C Infection
  Should Oral Glucose Tolerance Test Become a Standard of Care? (American Journal of Gastroenterology)
  Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause
  The metabolic abnormalities of type 2 diabetes can be reversed reproducibly by bariatric surgery. By quantifying the major pathophysiological abnormalities in insulin secretion and insulin action after surgery, the sequence of events leading to restoration of normal metabolism can be defined (Diabetologia)
  Real-Time Glucose Sensors in Children and Adolescents with Type-1 Diabetes - Mini review
  The results of our ongoing international pediatric ONSET trial will show the impact of this technology on learning to live with diabetes by having the biofeedback of glucose excursions from the onset of diabetes (Hormone Research)
  Assessing the Cardiovascular Safety of Diabetes Therapies
  Cardiovascular-outcome trials are not required at the time of approval of diabetes drugs. Since conducting such a trial is expensive and can take years, some worry that requiring an outcome trial before marketing would delay the availability or inhibit the development of new agents. Yet delay in obtaining these data could put many patients at undue risk, and physicians and patients must choose drugs without knowledge of the risk–benefit balance (NEJM, USA)
  10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
  Despite an early loss of glycemic differences, a continued reduction in microvascular risk and emergent risk reductions for myocardial infarction and death from any cause were observed during 10 years of post-trial follow-up (NEJM, USA)
  1st World Congress on Interventional Therapies for Type 2 Diabetes
  A comprehensive and multidisciplinary forum where leaders in the global health community will conduct an organized review and discussion of the latest scientific data and theories (Interventional Diabetology)
© Copyright Glycosmedia Partnership